Approval · Notice of Compliance 4682 · 1996

IMITREX: Notice of Compliance 4682

Issued March 7, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4682
Date: March 7, 1996
Company: Glaxo Wellcome Inc.Mississauga, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: 5-ht1 receptor agonist/migraine therapy

Products in this notice

Brand	DIN	Status today
IMITREX	02212153	Cancelled Post Market
IMITREX	02212161	Marketed
IMITREX	02212188	Marketed

Medicinal ingredients

SUMATRIPTAN SUCCINATE 50 MG per TAB
SUMATRIPTAN SUCCINATE 100 MG per TAB
SUMATRIPTAN SUCCINATE 12 MG per ML